H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features
Modern Pathology Oct 10, 2018
Makise N, et al. - As, the majority of malignant peripheral nerve sheath tumors are characterized by mutations in SUZ12 or EED, which encode polycomb repressive complex 2 (PRC2) components, and resulting deficiency in H3K27me3, researchers investigated H3K27me3 and PRC2 status in dedifferentiated chondrosarcoma (a rare bone sarcoma). They evaluate 19 dedifferentiated chondrosarcoma cases, among these, six (32%) showed immunohistochemical loss of H3K27me3 only in the dedifferentiated component, whereas the well-differentiated component retained H3K27me3. H3K27me3-deficient dedifferentiated chondrosarcomas and H3K27me3-intact dedifferentiated chondrosarcomas were histologically different, as the former invariably demonstrated dedifferentiated histology with a striking similarity to classic malignant peripheral nerve sheath tumor, comprising sweeping to swirling fascicles of relatively uniform spindle cells. Outcomes thereby suggest that H3K27me3 deficiency defines a novel subset of dedifferentiated chondrosarcoma that requires recognition because of its diagnostic and potential clinical implications.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries